chr9-32973654-T-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The ENST00000468275.6(APTX):c.*30A>G variant causes a 3 prime UTR change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
ENST00000468275.6 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- ataxia, early-onset, with oculomotor apraxia and hypoalbuminemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000468275.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APTX | NM_001195248.2 | MANE Select | c.875-2A>G | splice_acceptor intron | N/A | NP_001182177.2 | |||
| APTX | NR_160928.1 | n.888A>G | non_coding_transcript_exon | Exon 7 of 7 | |||||
| APTX | NM_001195251.2 | c.*30A>G | 3_prime_UTR | Exon 9 of 9 | NP_001182180.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| APTX | ENST00000468275.6 | TSL:1 | c.*30A>G | 3_prime_UTR | Exon 8 of 8 | ENSP00000420263.2 | |||
| APTX | ENST00000379817.7 | TSL:1 MANE Select | c.875-2A>G | splice_acceptor intron | N/A | ENSP00000369145.2 | |||
| APTX | ENST00000379819.6 | TSL:1 | c.875-2A>G | splice_acceptor intron | N/A | ENSP00000369147.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia Pathogenic:2
The observed invariant splice acceptor c.875-2A>G variant in APTX gene has been reported previously in compound heterozygous state in individual(s) affected with early-onset ataxia with oculomotor apraxia and hypoalbuminemia (Sun M, et al., 2019). The c.875-2A>G variant is absent in gnomAD Exomes. This variant has been submitted to the ClinVar database as Pathogenic. Loss of function variants have been previously reported to be disease causing. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at